Supporting a Role for the GTPase Rab7 in Prostate Cancer Progression
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Invasion and subsequent metastasis is the major cause of death from most cancers including prostate cancer. Herein we report on the potential tumor suppressive properties of Rab7, a GTPase that regulates trafficking of lysosomes. The movement of lysosomes to the cell surface in response to environmental cues increases the secretion of proteinases and cell invasion. We determined that Troglitazone and other members of the Thiazolidinedione family inhibit cell-surface directed lysosome trafficking and cathepsin B secretion through a Rab7-dependent mechanism. Moreover, Rab7 shRNA expressing cells were found to be more invasive in vitro and in vivo. Increased invasiveness was accompanied by elevated expression of the c-Met receptor and prolonged downstream signaling, thereby supporting a role for Rab7 as a mediator of signaling down-regulation. Taken together, these results suggested that Rab7 acts as a negative regulator of prostate tumor growth and invasion, providing further evidence for its potential as a tumor suppressor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jordens, I., Fernandez-Borja, M., Marsman, M., Dusseljee, S., Janssen, L., Calafat, J., Janssen, H., Wubbolts, R., & Neefjes, J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00531-0 · Cited by 811
Cited by
Mechanisms and functions of lysosome positioning
Pu, J., Guardia, C. M., Keren-Kaplan, T., & Bonifacino, J. S. (2016) · Journal of Cell Science · doi:10.1242/jcs.196287 · Cited by 570
Multiple Roles of the Small GTPase Rab7
Guerra, F., & Bucci, C. (2016) · Cells · doi:10.3390/cells5030034 · Cited by 397
Xu, R., Greening, D. W., Rai, A., Ji, H., & Simpson, R. J. (2015) · Methods · doi:10.1016/j.ymeth.2015.04.008 · Cited by 266
BORC/kinesin-1 ensemble drives polarized transport of lysosomes into the axon
Farías, G. G., Guardia, C. M., De Pace, R., Britt, D. J., & Bonifacino, J. S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616363114 · Cited by 228
mTORC2: The other mTOR in autophagy regulation
Ballesteros‐Álvarez, J., & Andersen, J. K. (2021) · Aging Cell · doi:10.1111/acel.13431 · Cited by 177
“…lysosomes can undergo changes in pH, subcellular localization, or composition; reductions in RAB7 expression promote lysosomal relocation to the cell periphery which has been documented to occur in prostate cancer and associated with increased tumor invasiveness (Steffan et al., 2014).”
BackgroundRUFY3 and RUFY4 are ARL8 effectors that promote coupling of endolysosomes to dynein-dynactin
Keren-Kaplan, T., Sarić, A., Ghosh, S., Williamson, C. D., Jia, R., Li, Y., & Bonifacino, J. S. (2022) · Nature Communications · doi:10.1038/s41467-022-28952-y · Cited by 79
Dykes, S. S., Gray, A. L., Coleman, D. T., Saxena, M., Stephens, C. A., Carroll, J. L., Pruitt, K., & Cardelli, J. A. (2016) · Oncotarget · doi:10.18632/oncotarget.8832 · Cited by 69
“We have previously described the role of lysosome distribution in tumor cell invasion and cathepsin B secretion and found that the lysosomal GTPase Rab7, by promoting perinuclear lysosome localization, is a potential tumor suppressor [8].”
InfluentialSelf-citation
Metadata
- Authors
- Steffan, J. J., Dykes, S. S., Coleman, D. T., Adams, L. K., Rogers, D., Carroll, J. L., Williams, B. J., & Cardelli, J. A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-02-05
- Volume
- 9
- Issue
- 2
- Pages
- e87882
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1996156539
- Cited by
- 73
- References
- 1
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.